Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren in Heart Failure with Renal Dysfunction
NCT00881439Phase 2Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Aliskiren with Placebo (2 arms). Primary endpoint: Change in renal blood flow at 6 months. Started Apr 2009; status: terminated.
02
Drugs
aliskiren
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00881439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00881439.